Cargando…

Vascular endothelial growth factor (VEGF) expression in muscle tissue and the effect of corticosteroid therapy in patients with poly- and dermatomyositis

Detalles Bibliográficos
Autor principal:	Lundberg, IE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2002
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273115/ http://dx.doi.org/10.1186/ar451

Ejemplares similares

Covariation of MHC class I and CD163 positive macrophages in skeletal muscle tissue of polymyositis and dermatomyositis patients after treatment with high-dose intravenous immunoglobulin (IVIg)
por: Barbasso, S, et al.
Publicado: (2003)

HMGB1, a new proinflammatory molecule of interest in polymyositis and dermatomyositis patients
por: Grundtman, C, et al.
Publicado: (2003)

Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor (VEGF) levels in patients with rheumatoid arthritis: a pilot study
por: Strunk, J, et al.
Publicado: (2004)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Interference with platelet-derived growth factor-induced signalling in vascular smooth muscle cells by roscovitine
por: Sroka, Irene, et al.
Publicado: (2008)

Muscular mass and subcutaneous fat changes according to duration of ICU hospitalization with corticosteroid and muscle relaxant intake
por: Moukas, M, et al.
Publicado: (2000)

TNF-α blockade in early rheumatoid significantly reduces serum VEGF and ultrasonographic measures of synovitis and joint vascularity by 18 weeks
por: Taylor, PC, et al.
Publicado: (2002)

A new approach to study angiogenesis in rheumatoid arthritis by power Doppler sonography and serum vascular endothelial growth factor level measurement
por: Strunk, J, et al.
Publicado: (2004)

Does VEGF polymorphism play a role in the treatment success with VEGF inhibitors in patients with CNV?
por: Boltz, Agnes, et al.
Publicado: (2010)

Protective effect of resveratrol on TNF-α-treated vascular endothelial cells
por: Xu, Jingyu, et al.
Publicado: (2012)

HIF-1 mediated upregulation of VEGF and VEGF-R in systemic sclerosis (SSc): Imbalance with angiostatic factors suggests VEGF as a novel option for the treatment of ischemia in patients with SSc
por: Distler, O, et al.
Publicado: (2002)

Automated and Reproducible Detection of Vascular Endothelial Growth Factor (VEGF) in Renal Tissue Sections
por: Macedo, Nayana Damiani, et al.
Publicado: (2019)

Effect of continuous hemodiafiltration (CHDF) on vascular endothelial cell function in sepsis patients
por: Ikeda, K, et al.
Publicado: (2003)

A placebo-controlled study on the effects of corticosteroid inhalation therapy in ammonia induced lung injury in rabbits
por: Sjöblom, E, et al.
Publicado: (1998)

Human vascular endothelial cells produce TNF-α after stimulation with proinflammatory cytokines
por: Ranta, V, et al.
Publicado: (1999)

Corticosteroids reduce inotrope requirements in hypotensive liver failure
por: Harry, R, et al.
Publicado: (2001)

Correlation of vascular smooth muscle cell phenotype and cGMP signalling
por: Lehners, Moritz, et al.
Publicado: (2015)

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
por: Akagi, K, et al.
Publicado: (2000)

In vitro performances of a valved holding chamber with inhaled corticosteroids
por: Boukhettala, Nabile, et al.
Publicado: (2015)

Expression and regulation of bone morphogenetic protein antagonists in vascular smooth muscle cells
por: Maciel, TT, et al.
Publicado: (2003)

Tormentic acid inhibits proliferation and induces apoptosis in vascular smooth muscle cells
por: Fogo, AS, et al.
Publicado: (2003)

Differential effect of corticosteroid therapy on the cytoplasmic cytokine expression in CD4 and CD8 positive T cells from lupus patients
por: Kiss, E, et al.
Publicado: (2001)

Expression of vascular endothelial growth factor (VEGF) in equine sarcoid
por: Martano, Manuela, et al.
Publicado: (2018)

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
por: Barratt, Shaney L., et al.
Publicado: (2018)

Implication of C-type natriuretic peptide derived from vascular endothelial cells on blood pressure regulation
por: Nakao, Kazuwa, et al.
Publicado: (2015)

23. Endothelial Specific CXCL12 Regulates Neovascularization Through Fibroblast VEGF Signaling during Tissue Repair and Regeneration
por: Hostler, Andrew C., et al.
Publicado: (2023)

Inhibition of growth factor mediated Akt phosphorylation in vascular smooth muscle cells by resveratrol: the contribution of SH2 domain containing phosphatase 2 and reactive oxygen species
por: Schreiner, Cornelia E, et al.
Publicado: (2008)

The Effects of `Pulse' Corticosteroids on Mediators of Inflammation and Joint Damage in the Rheumatoid Synovium
por: Youssef, Peter
Publicado: (2000)

TNFa, IL10 and TGFb1 gene polymorphism in myositis and mixed connective tissue disease (MCTD)
por: Hassan, A, et al.
Publicado: (2001)

Role of perivascular adipose tissue in endothelial dysfunction of adipose triglyceride lipase-deficient mice
por: Pail, Karoline, et al.
Publicado: (2012)

Corticosteroids reduce neuron-specific-enolase liberation after cardiopulmonary bypass in men
por: Schmartz, D, et al.
Publicado: (2000)

Asthma diagnosis and treatment – 1018. Effect of inhaled corticosteroids with long-acting beta2 agonists vs. inhaled corticosteroids alone on asthma control in children: results from national ashtma survey
por: Lockey, Richard F, et al.
Publicado: (2013)

Enhancement of musculocutaneous nerve reinnervation after vascular endothelial growth factor (VEGF) gene therapy
por: Haninec, Pavel, et al.
Publicado: (2012)

Effects of aging on endothelial progenitor cells (EPCs) subpopulations in peripheral blood: a possible rationale for age-associated vascular dysfunction
por: Lombardo, M F, et al.
Publicado: (2010)

Corticosteroids reduce early troponin-T release after cardiac surgery with cardiopulmonary bypass in men
por: Tabardel, Y, et al.
Publicado: (1999)

EHMTI-0318. The place of corticosteroids in migraine attack management: systematic review and critical appraisal
por: Woldeamanuel, YW, et al.
Publicado: (2014)

Using inhaled corticosteroids can reduce the decline of lung function in asthmatics: pilot study
por: Almeida, Paula, et al.
Publicado: (2015)

Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
por: Schmidinger, Manuela
Publicado: (2013)

Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy
por: Lin, Shuhua, et al.
Publicado: (2016)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ltbnftcf8oarvlnj4canl4u32u